University of Cambridge > Talks.cam > Cancer Research UK Cambridge Centre Lectures in Cancer Biology and Medicine > The AKT inhibitor Capivasertib (AZD5363): from discovery to clinical proof of concept

The AKT inhibitor Capivasertib (AZD5363): from discovery to clinical proof of concept

Add to your list(s) Download to your calendar using vCal

If you have a question about this talk, please contact Justin Holt.

This talk has been canceled/deleted

Abstract not available

This talk is part of the Cancer Research UK Cambridge Centre Lectures in Cancer Biology and Medicine series.

Tell a friend about this talk:

This talk is included in these lists:

This talk is not included in any other list

Note that ex-directory lists are not shown.

 

© 2006-2024 Talks.cam, University of Cambridge. Contact Us | Help and Documentation | Privacy and Publicity